Augmentation of DNA synthesis in placental and fetal tissues in utero by maternal growth hormone treatment.

The influence of maternal exogenous growth hormone treatment on in utero conceptus development was evaluated in the rat. The periods of response and stimulation of DNA synthesis on embryo/fetal and placental tissues were assessed by subcutaneous injections of ovine growth hormone (oGH) preparations during pregnancy days 11-15, autopsied on day 16; and during pregnancy days 11-20 and 16-20, autopsied on day 21. To determine DNA biosynthesis potential, thymidine (methyl-3H) was administered through the jugular vein 14-16 h prior to sacrifice. DNA content and uptake of radiolabeled thymidine into DNA were analyzed for whole embryos on day 16, and for fetal liver, brain and remaining body tissues on day 21 of pregnancy. Placental tissues from oGH-treated mother and controls were also quantified for DNA content and radiolabeled thymidine uptake. oGH treatment produced a significant increase (p < 0.05) in radiolabeled thymidine uptake into DNAs of different fetal organs compared to saline-treated controls matched for weight and litter number during the latter part of gestation (fetal histogenesis period; pregnancy days 16-20). The stimulatory influence of maternal growth hormone treatment on DNA contents and radiolabled thymidine uptake on placental tissues at this period of gestation was also significantly different from that of the controls. Rat conceptus tissues (embryos and placentas) during the organogenesis period of early gestation (days 11-15) appeared to be unresponsive to such treatment. Thus, these results suggest that maternal growth hormone influences conceptus growth during the latter part of gestation and activation of placental functions may be an important aspect of stimulation of cell proliferation in the rat fetus.